During the past decade, Charlotte Lung and Health Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Charlotte Lung and Health Center" are "Chronic Bronchitis" (2 trials), "Chronic Obstructive Pulmonary Disease" (2 trials), "Emphysema" (2 trials) and "Asthma" (1 trials). Many other conditions were trialed in "Charlotte Lung and Health Center" in a lesser frequency.

Most popular intervention types in "Charlotte Lung and Health Center" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Salmeterol" (2 trials), "Placebo" (1 trials), "arformoterol" (1 trials), "arformoterol tartrate inhalation solution" (1 trials) and "levalbuterol" (1 trials). Other intervention names were less common.

The vast majority of trials in "Charlotte Lung and Health Center" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Charlotte Lung and Health Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Charlotte Lung and Health Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Charlotte Lung and Health Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".